Celldex Therapeutics Inc (CLDX)
Net Income Growth
-50.59%
TTM · Period ending:
CLDX Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-50.59%period ending
Latest reported-50.59%period ending
CLDX TTM Net Income YoY % (78.57% → -50.59%)
Year-over-year change
High-resolution chart · PNG
CLDX net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| -142.3176% | |
| -122.2707% | |
| -94.3125% | |
| -20.9% | |
| 79.6007% | |
| 79.7881% | |
| 78.1678% | |
| 80.3922% | |
| -344.2623% | |
| -321.4286% | |
| -295.4198% | |
| -264.2857% | |
| -46.988% | |
| -15.5963% | |
| -20.1835% | |
| -60.9195% | |
| 12.6316% | |
| -39.7436% | |
| -31.3253% | |
| 30.4% | |
| 23.3871% | |
| 35.5372% | |
| 28.4483% | |
| -32.9787% | |
| -40.9091% | |
| -51.25% | |
| -48.7179% | |
| -40.2985% | |
| -60% | |
| -48.1481% | |
| -63.4146% | |
| -22.2222% | |
| -17.3913% | |
| 8.8889% | |
| -21.6216% | |
| -35.2941% | |
| -86.3636% | |
| -246.1538% | |
| -184.6154% | |
| -277.7778% | |
| -100% | |
| 23.5294% | |
| 7.1429% | |
| 18.1818% | |
| 26.6667% | |
| -30.7692% | |
| -27.2727% | |
| 8.3333% | |
| -25% | |
| -30% | |
| -22.2222% | |
| -50% | |
| 64.7059% | |
| 74.359% | |
| 78.5714% |